Skip to content
Governance Register

← US public companies

Summit Therapeutics Inc.

SEC CIK 1599298 · SMMT · last insider filing 2026-06-12

Directors (from insider filings)

NameCapacity as filedFilings
Duggan Robert W Director · See Remarks filed 2020 - 2026
Zanganeh Maky Director · Co-Chief Executive Officer filed 2020 - 2026
Soni Manmeet Singh Director · Chief Operating Officer filed 2020 - 2026
Ronaghi Mostafa Director filed 2024 - 2026
Huber Jeff Director filed 2024 - 2026
Booth Robert F. Director filed 2022 - 2026
Clark Kenneth A Director filed 2021 - 2026
Cesano Alessandra Director filed 2022 - 2026
Xia Yu Director filed 2023 - 2026
Mahatme Ujwala Director filed 2020 - 2024
Gayko Urte Director filed 2021 - 2022
Wang Luhua Director filed 2021 - 2021
Erdtmann Rainer M Director filed 2020 - 2021
Stefanov Ventzislav Director · See Remarks filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Anand Bhaskar Chief Accounting Officer filed 2024 - 2026
Dhingra Ankur Chief Financial Officer filed 2022 - 2024
Maranian Jeffrey R VP, Corporate Controller filed 2021 - 2021
Donaldson Michael Paul Chief Financial Officer filed 2020 - 2021
Powell David Jonathan Chief Scientific Officer filed 2020 - 2020
Graham Camilla Chief Clinical Affairs Officer filed 2020 - 2020
Houbiers Jos Chief Medical Officer filed 2020 - 2020

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.